Want to see GENB full AI Analyst Report?
Generate Biomedicines, Inc. (GENB) Ownership - Who Owns Generate Biomedicines, Inc.?
Generate Biomedicines, Inc. (GENB) Ownership Overview
- 52.37% Insiders
- 8.44% Mutual Funds
- 1.60% Other Institutional Investors
- 4.50% ETFs
- 33.10% Public Companies and Individual Investors
The ownership structure of Generate Biomedicines, Inc. (GENB) stock is a mix of institutional, retail, and individual investors. Approximately 14.53% of the company’s stock is owned by Institutional Investors, 52.37% is owned by Insiders, and 33.10% is owned by Public Companies and Individual Investors.
The ownership structure of Generate Biomedicines, Inc. (GENB) stock is a mix of institutional, retail, and individual investors. Approximately 10.03% of the company’s stock is owned by Institutional Investors, 52.37% is owned by Insiders, and 4.50% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 05, 2026 | Michael Nally | $240,000 | |
| Mar 01, 2026 | Noubar Afeyan | $75,000,000 | |
| Mar 01, 2026 | Jason Silvers | $32,000 | |
| Mar 01, 2026 | Beth Grous | $4,800 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Ark Investment Management Llc | $21,671,489 | |
| Jun 30, 2026 | $28,003,626 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Noubar Afeyan | 62,673,117 | Insider | 48.83% | 906,253,272 |
| Noubar Afeyan | 62,673,117 | Institution | 48.83% | 906,253,272 |
| Smallcap World Fund Inc | 3,752,630 | Institution | 2.92% | 54,263,030 |
| Fidelity Mt. Vernon Street Trust | 3,437,903 | Institution | 2.68% | 49,712,077 |
| Michael Nally | 2,889,154 | Insider | 2.25% | 41,777,167 |
| Vanguard | 2,342,403 | Institution | 1.82% | 33,871,147 |
| Ark | 1,736,349 | Institution | 1.35% | 25,107,607 |
| John Toomey, Jr. | 1,722,210 | Institution | 1.34% | 24,903,157 |
| Felix Baker | 1,423,602 | Institution | 1.11% | 20,585,285 |
| Cathie Wood | 1,284,617 | Institution | 1.00% | 18,575,562 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Smallcap World Fund Inc | 3,752,630 | Institution | 2.92% | 54,263,030 |
| Fidelity Mt. Vernon Street Trust | 3,437,903 | Institution | 2.68% | 49,712,077 |
| Vanguard Index Funds | 1,113,355 | Institution | 0.87% | 16,099,113 |
| Jpmorgan Trust Ii | 580,246 | Institution | 0.45% | 8,390,357 |
| T. Rowe Price Health Sciences Fund, Inc. | 314,964 | Institution | 0.25% | 4,554,379 |
| Eaton Vance Growth Trust | 308,946 | Institution | 0.24% | 4,467,359 |
| Fidelity Concord Street Trust | 300,653 | Institution | 0.23% | 4,347,442 |
| Fidelity Salem Street Trust | 293,497 | Institution | 0.23% | 4,243,967 |
| Jpmorgan Trust I | 244,048 | Institution | 0.19% | 3,528,934 |
| Vanguard Scottsdale Funds | 166,913 | Institution | 0.13% | 2,413,562 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,890,176 | Institution | 1.47% | 28,390,444 |
| ARK | 1,628,671 | Institution | 1.27% | 23,550,583 |
| iShares | 622,084 | Institution | 0.48% | 9,810,265 |
| JPMorgan | 289,750 | Institution | 0.23% | 4,569,358 |
| Vanguard | 282,345 | Institution | 0.22% | 4,240,822 |
| iShares | 160,284 | Institution | 0.12% | 2,317,707 |
| ALPS | 157,150 | Institution | 0.12% | 2,272,389 |
| Vanguard | 141,922 | Institution | 0.11% | 2,131,668 |
| Schwab | 133,966 | Institution | 0.10% | 2,112,644 |
| ARK | 92,534 | Institution | 0.07% | 1,459,261 |
FAQ
Who Owns Generate Biomedicines, Inc. (GENB)?
According to the latest TipRanks data, approximately 1.60% of the company's stock is held by institutional investors, 52.37% is held by insiders, and 33.10% is held by retail investors.
What percentage of Generate Biomedicines, Inc. (GENB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.60% of Generate Biomedicines, Inc. (GENB) stock is held by institutional investors.
What percentage of Generate Biomedicines, Inc. (GENB) stock is held by retail investors?
According to the latest TipRanks data, approximately 33.10% of Generate Biomedicines, Inc. (GENB) stock is held by retail investors.
Who owns the most shares of Generate Biomedicines, Inc. (GENB)?
Noubar Afeyan owns the most shares of Generate Biomedicines, Inc. (GENB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.